Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Prestige Scholars Programme invests in promising academics
2015-06-24

Photo: Sonia Small

Whilst many academics find it challenging to have sustainable funding for specific projects, it is often just as challenging to find relevant exposure and good mentorship programmes to fully prepare academics toward becoming full professors.

Prof Jonathan Jansen, Vice-Chancellor and Rector of the UFS, designed the Vice-Chancellor’s Prestige Scholars Programme (PSP) specifically targeting newly-completed post-doctoral students who are already members of the academic staff.

The goal is to select the most promising young scholars and to make substantial institutional investment in their development.

To date, the PSP has produced 2 Fulbright scholars; 10 National Research Foundation (NRF) rated scholars; 1 NRF Blue Skies research project and 14 NRF Thuthuka-funded projects. These scholars work with the best academics at leading universities on three continents.

Prof Jackie du Toit, co-director of the programme, explains that while the PSP does not provide funding, it is a great programme to empower scholars by means of assistance towards generating funding from outside sources.

Prof Du Toit co-directs this programme with Proff Corli Witthuhn, Vice-Rector: Research and Niel Roos from the Department of Africa Studies.

“The PSP bases its approach to funding on the philosophy that young scholars are to be encouraged towards financial independence, based on a viable postdoctoral project that would sustain their scholarship for five to eight years post PhD. We believe that the cachet and long-term sustainability of existing funding programmes such as Fulbright outweighs the short-term benefits of automatic funding from the PSP. We also endeavour to teach young scholars to work cleverly within institutional parameters, rather than leave them floundering once they step off the active PSP.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept